ARTICLE | Clinical News
VX-148: Began Phase I trial
January 2, 2001 8:00 AM UTC
Vertex Pharmaceuticals Inc. (VRTX), Cambridge, Mass. Product: VX-148 Business: Infectious diseases Therapeutic category: Cell proliferation Target: IMPDH Description: Oral small molecule inhibitor of...